<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04121871</url>
  </required_header>
  <id_info>
    <org_study_id>Oral Fungal Infection</org_study_id>
    <nct_id>NCT04121871</nct_id>
  </id_info>
  <brief_title>Molecular Characterization of Candida Auris</brief_title>
  <acronym>OC</acronym>
  <official_title>Formulation Development and In-Vitro Studies of Efficacy of Botanical Extracts Against Candida Auris</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Islamia University of Bahawalpur</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Islamia University of Bahawalpur</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Candida auris is emerging fungal opportunistic pathogen in developing countries. Much studies
      has been conducted on Candida albicans. there was a dire need to investigate this alarming
      threat. Our hypothesis is that by recording the patients diagnosed with oropharygneal
      candidiasis and collecting clinical swab samples from these patients will be fruitful if
      microbiological isolation, identification and molecular characterization will be done. So
      this is the first study on C. auris in south punjab, Pakistan. Aim of this study is to
      collect epidemiological data of C. auris.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 15, 2019</start_date>
  <completion_date type="Anticipated">February 29, 2020</completion_date>
  <primary_completion_date type="Anticipated">February 29, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence of C. auris</measure>
    <time_frame>From November 15, 2019 to February 29, 2020</time_frame>
    <description>patients from selected localities will be recorded along with total patients in that category, prevalence will be calculated on the record collected from specified duration of study</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Seasonality of C. auris infection</measure>
    <time_frame>From November 15, 2019 to February 29, 2020</time_frame>
    <description>Number of patients recorded during different months will be the source of calculation of seasonality index of the C. auris infection</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Drug susceptibility</measure>
    <time_frame>From November 15, 2019 to February 29, 2020</time_frame>
    <description>Antifungal drug discs will be used for assessing the antfungal drugs susceptibility</description>
  </primary_outcome>
  <enrollment type="Anticipated">1152</enrollment>
  <condition>Oral Fungal Infection</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <description>Not required</description>
  </intervention>
  <biospec_retention>None Retained</biospec_retention>
  <biospec_descr>
    <textblock>
      Clinical oral swab samples from infected patients will be collected
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All individuals are equally eligible to be selected in the study
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pre-diagnosed Patients of both gender from pre-selected localities

        Exclusion Criteria:

          -  Healthy individuals or individuals having no oral fungal infection individuals above
             100 years of age
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jafi H Shirazi, M.Phil</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Islamia University of Bahawalpur</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jafir H Shirazi, M.Phil</last_name>
    <phone>00923360025271</phone>
    <email>jafir.shirazi@iub.edu.pk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Bahawal Victoria Hospital Bahawalpur</name>
      <address>
        <city>Bahawalpur</city>
        <state>Punjab</state>
        <zip>63100</zip>
        <country>Pakistan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Irfan Aslam, M.Phil</last_name>
    </contact>
    <investigator>
      <last_name>Farhan Ali, Pharm-D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Muhammad Waseem, Pharm-D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Civil Hospital Jhangi Wala Road Bahawalpur</name>
      <address>
        <city>Bahawalpur</city>
        <state>Punjab</state>
        <zip>63100</zip>
        <country>Pakistan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Irfan Aslam, M.Phil</last_name>
    </contact>
    <investigator>
      <last_name>Farhan Ali, Pharm-D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Muhammad Waseem, Pharm-D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Pakistan</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>October 7, 2019</study_first_submitted>
  <study_first_submitted_qc>October 9, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 10, 2019</study_first_posted>
  <last_update_submitted>December 15, 2019</last_update_submitted>
  <last_update_submitted_qc>December 15, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 17, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Islamia University of Bahawalpur</investigator_affiliation>
    <investigator_full_name>Jafir Hussain Shirazi</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Candida auris</keyword>
  <keyword>Oral Fungal Infection</keyword>
  <keyword>Candidiasis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mycoses</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Individual privacy is prime important, hence data will not be shared</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

